grade
pharmaceutical primary standard
API family
trimethadione
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
CN1C(=O)OC(C)(C)C1=O
InChI
1S/C6H9NO3/c1-6(2)4(8)7(3)5(9)10-6/h1-3H3
InChI key
IRYJRGCIQBGHIV-UHFFFAOYSA-N
Gene Information
human ... CACNA1G(8913), CACNA1H(8912), CACNA1I(8911)
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Trimethadione EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
Other Notes
Sales restrictions may apply.
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Repr. 1B
저장 등급
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
[Fetal trimethadione effects].
Y Nakane
Ryoikibetsu shokogun shirizu, (30 Pt 5)(30 Pt 5), 94-95 (2000-11-01)
E Tanaka et al.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology, 104(2), 205-207 (1993-02-01)
1. Trimethadione (TMO) has the properties required of probe drugs for the evaluation of hepatic oxidizing capacity in vivo. 2. TMO is demethylated to dimethadione (DMO), its only metabolite, in the liver after oral administration. 3. In rats with various
[Fetal trimethadione syndrome].
T Nagai
Ryoikibetsu shokogun shirizu, (33)(33), 704-704 (2001-07-21)
국제 무역 품목 번호
| SKU | GTIN |
|---|---|
| T2100000 | 04061833801376 |